Home » Prices » NASDAQ:RETA

Reata Pharmaceuticals, Inc. stock price

Today's NASDAQ:RETA chart, history & news

Price:
112.95 USD
Change:
+0.17 (0.15%)
Key Stats
Price open
Previous close 112.78
Market cap 3.23B
Volume 165.02K
Day high 116.88
Day low 112.03
Year high 257.97
Year low 88.17
Year to date change -45.42%
P/E Ratio -10.52
Company Profile
Fundamentals
Insider Information
News

About Reata Pharmaceuticals, Inc.

Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by W. Christian Wigley, Waldemar Priebe, Philip J. Thomas, Jef Karel de Brabander, Thomas C. Südhof, Jonathan M. Graff and J. Warren Huff on September 1, 2002 and is headquartered in Irving, TX.

Company information

Company name
Reata Pharmaceuticals, Inc.
Exchange
Sector
Health Technology
Industry
Pharmaceuticals: Major
Employees
220
CEO
J. Warren Huff
Address
5320 Legacy Drive, Plano, TX, 75024
Country
United States
Contact information
1.972.865.2219
Website
http://www.reatapharma.com

Related companies

Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.